A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery

Completed · Phase 2/Phase 3

Conditions studied: Venous Thromboembolism, Arthroplasty, Replacement, Hip

In brief

The purpose of this study is to evaluate the efficacy and safety of various doses of YM150 (the experimental drug) compared to enoxaparin in the prevention of venous thromboembolism in patients that are undergoing elective hip replacement surgery.

Key facts

Study ID

NCT00902928

Run by

Astellas Pharma Europe B.V.

People needed

1992

Starts

2009-04-01

Expected to finish

2010-08-01

Last updated by the study team

2015-10-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject is scheduled for elective hip replacement surgery

You may not qualify if…

• Subject has active bleeding or any condition associated with increased risk of bleeding
• Subject has had major trauma or surgery within 3 months before planned hip replacement surgery or requires major surgery or other invasive procedures with potential for uncontrolled bleeding during the study
• Subject has had an MI or stroke within 3 months before planned hip replacement surgery

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Tuscon, Arizona, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Long Beach, California, United States
• Study site — Torrance, California, United States
• Study site — Aurora, Colorado, United States
• Study site — DeLand, Florida, United States
• Study site — Pinellas Park, Florida, United States
• Study site — Sarasota, Florida, United States
• Study site — Tamarac, Florida, United States
• Study site — Meridian, Idaho, United States
• Study site — Lexington, Kentucky, United States
• Study site — Baltimore, Maryland, United States
• Study site — Charleston, South Carolina, United States
• Study site — Austin, Texas, United States
• Study site — Dallas, Texas, United States
• Study site — Houston, Texas, United States
• Study site — Box Hill, Victoria, Australia
• Study site — Ringwood East, Victoria, Australia
• Study site — Windsor, Victoria, Australia
• Study site — Perth, Western Australia, Australia
• Study site — Kogarah, Australia
• Study site — Graz, Austria
• Study site — Innsbruck, Austria
• Study site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.